Mr. President, I have risen many times over the past years in support of the legislation that is now before this body, legislation that will unlock the hope of stem cell research for millions of Americans and tens of thousands of Nevadans…
Mr. President, I have risen many times over the past years in support of the legislation that is now before this body, legislation that will unlock the hope of stem cell research for millions of Americans and tens of thousands of Nevadans who suffer from cancer, Alzheimer's, diabetes, Parkinson's, spinal cord injuries, heart disease, Lou Gehrig's disease, and many other diseases.
Initially, I extend my appreciation to Senator Harkin. Others worked hard on this legislation. Senator Kennedy and Senator Feinstein have done a wonderful job, but Senator Harkin, from his position as the chair and/or ranking member of the labor subcommittee on appropriations, has worked with Senator Specter--back and forth, the two of them have worked to come up with stem cell legislation.
Senator Harkin has been a pioneer and a leader in this cause. I admire and respect him for a lot of what he has done as a longtime Member of the Senate, but I know I have more respect for him for what he has done on this legislation.
He has a tremendously good staff: Erik Fatemi, Ellen Murray, and Adrian Hatlett. They have done good work.
I have to throw a bouquet to my longtime, very important legislative advocate whom I have working for me, Carolyn Gluck. She has worked very hard on this issue. I appreciate her hard work.
I have spoken in the past about a man I met who is in a wheelchair in Boulder City, NE. This man suffers from Parkinson's. I asked him why he was in his wheelchair. He told me. After this legislation was vetoed by President Bush, he felt so bad because he believes with this legislation he will be able to walk again and not be confined to that wheelchair.
I have spoken of an 18-year-old twin from Las Vegas. She came to Washington for the first time when she was a little girl. She has suffered from juvenile diabetes for most of her life. She has had tens of thousands of needle pricks over these years--tens of thousands. But this 18-year-old girl still remains optimistic because of this legislation--optimistic for a healthy adulthood. Not only does she feel that way but her twin sister feels the same way.
I have spoken of a 23-year-old man from Henderson who just weeks after his high school graduation was in a car accident which left him a quadriplegic and whose mother wrote to me a plaintive letter hoping, praying because of this legislation her son one day will lead a more normal life.
The plight and suffering of these friends and neighbors pains my heart. But sadly, their stories are far from unique. Mr. President, 100 million Americans suffer just like them. Those who suffer are parents, are children, are friends, are our neighbors. They know that stem cell research is not a guarantee or imaginable, but they know it holds promise, they know it holds hope, real hope, yes, scientific hope. They know it because the world's leading experts tell us so.
In a letter to President Bush, 80 Nobel laureates wrote:
. . . for disorders that prove not to be treatable with
adult stem cells, impeding human pluripotent stem cell
research risks unnecessary delay for millions of patients who
may die or endure needless suffering while the effectiveness
of adult stem cells is evaluated.
This is a statement from 80 Nobel Prize winners.
According to the National Academies of Science, research on both embryonic and adult stem cells is needed ``to most effectively advance the scientific and therapeutic potential of regenerative medicine.''
In a letter dated a few days ago, April 9, Dr. Harold Varmus, former Director of the National Institutes of Health and now the President of Memorial Sloan-Kettering Cancer Center and also a Nobel laureate wrote:
S. 5 represents an important step forward for human
embryonic stem cell research, a new field that offers great
promise for the replacement of damaged cells, the
understanding of the mechanics of disease, and the
development of the testing of new drugs. Unfortunately,
current Federal policy, in place since 2001, has not kept
pace with the speed of scientific discovery and is today of
limited value to the scientific community.
A man whom I have met, Dr. Jeffery Bluestone, a leading diabetes researcher and director of the Diabetes Center at the University of California, San Francisco, said:
We have made great strides in understanding the role of the
immune system in diabetes, but fully pursuing both embryonic
and adult stem cell research will build on our current
successes and could be critical in the ultimate treatment and
cure of patients who suffer from this disease.
I have spoken to him personally, and he has said we are going to cure, in the next few years, diabetes. They need this ability to go forward.
The other day I received a letter signed by more than 500 leading organizations from all around the country. It crossed the political spectrum. It includes the AARP, the American Medical Association, Novartis Pharmaceuticals, the Mayo Clinic, the Episcopal Church, Iraq Veterans for a Cure, the American Diabetes Association, Memorial Sloan- Kettering Cancer Center, Harvard University, and the Parkinson's Action Network--to name 11 of 500 organizations.
They spoke with one voice in support of S. 5, writing:
The Stem Cell Research Enhancement Act will move stem cell
research forward in our country. The bill holds promise for
expanding medical breakthroughs and hope for millions of
patients and their loved ones.
Even President Bush's own Director of the National Institutes of Health, Dr. Elias Zerhouni, endorsed the need to pursue embryonic stem cell research in addition to alternative forms of research. At a Senate hearing a few weeks ago he said:
It's not possible for me to see how we can continue the
momentum of science and research with the stem cell lines we
have at NIH. . . . [F]rom my standpoint as NIH director, it
is in the best interests of our scientists, our science, and
our country that we find ways and the nation finds a way to
go full-speed across adult and embryonic stem cells equally.
Americans, by a huge majority, favor stem cell research because they see the suffering of their own friends and relatives and neighbors, similar to those described in my introduction today. They hear the opinions of experts similar to those I just mentioned and they put their faith in science.
Californians, by ballot, voted, they agreed to spend billions of their own State Treasury on stem cell research, thus challenging the obstinacy of President Bush.
Congress has supported this important cause already. Two years ago the House of Representatives passed something called H.R. 810, the Stem Cell Research Enhancement Act, with bipartisan support. Last year the Senate followed suit, as Republicans and Democrats united to pass a bill that will expand the number of stem cell lines available to federally funded researchers, while ensuring that strict ethical guidelines are followed.
Yet when we sent this bipartisan bill to President Bush's desk, he responded with a veto--his only veto in 6 years, taking away the hope for millions.
Today, as hundreds of millions of Americans wait for progress, our scientists, our innovators are marking time, waiting for President Bush to keep hope alive. The wishes of the American people and the overwhelming weight of evidence, scientific evidence, should trump the narrow ideology of President George Bush.
Yesterday and today we debated S. 5, the Stem Cell Research Enhancement Act, a bill that is similar to the one both the House and Senate passed last year with strong bipartisan support. The House passed it again this year. S. 5 authorizes federally funded research on stem cell lines derived from excess embryos from fertility clinics, embryos that would otherwise be discarded--discarded, thrown away, trashed. These potentially discarded embryos could and should be used to advance lifesaving research.
At the same time, our bill acknowledges the important ethical issues at stake and enacts stronger research guidelines than exist in the President's current policy. Because we believe that all forms of promising research should move forward, S. 5 includes a provision that supports the advancement of alternative forms of stem cell research
based on the Santorum-Specter bill that passed the Senate unanimously last year.
Tonight the Senate will also consider another measure sponsored by Senators Coleman and Isakson. Similar to our bill, theirs would promote research in alternative methods for deriving stem cells, some say. However, unlike our bill, this bill would retain the President's restrictions on stem cell research. The legislation is, in my opinion, more political than substantive, more political than scientific. The Coleman-Isakson bill is not a substitute for S. 5.
I know some of my colleagues will disagree. I am not going to vote for it. I think S. 30 is a cover vote, and I am not going to provide any cover. S. 5 is the only bill being discussed that will lift the restrictions that are impeding scientific research and can lead to new treatments and cures of many dread conditions and diseases. For the 100 million Americans who suffer from diseases that could be treated as a result of stem cell research, there is simply no alternative to S. 5.
By supporting the Stem Cell Research Enhancement Act, we are renewing our faith in society's steady march forward. Whether expanding our frontiers, putting a man on the Moon, or mapping the human genome, America has always embraced great scientific challenges that hold even greater promise. It is who we are and it is a commitment to the American people that we must honor.
Jonas Salk, a great American scientist who moved science forward regarding the dread polio or, as they called it, infantile paralysis, when he invented the vaccine, once said, ``Our greatest responsibility is to be good ancestors.''
If we give our scientists the tools to succeed and give hope to the millions who suffer, we will be doing just that, good ancestors.
I yield any time I have.
Have the yeas and nays been ordered?
I ask for the yeas and nays.
Also, before the Chair enters an order, I ask for the yeas and nays on the second vote that we have this evening.